Advair Diskus Vs Wixela Inhub

Wixela inhub was first approved by the fda in january 2019.

Advair diskus vs wixela inhub. The active ingredients wixela inhub and advair diskus are the same and have been demonstrated in clinical studies to help improve lung function all day so appropriate asthma or copd patients can breathe better. Mylan will make the generic alternative to fluticasone salmeterol which will be called wixela inhub and come in the same strengths as the original brand name product. The study included patients aged 18 years with mild to moderate persistent asthma n 1127.

Fda approved the first generic version of blockbuster drug advair fluticasone salmeterol for asthma maintenance treatment in patients aged 4 and up and also for maintenance treatment and prevention of exacerbations in chronic obstructive pulmonary disease copd. Wixela inhub prices coupons and patient assistance programs. Your doctor will choose the dose that is right for you important safety information continued do not use wixela inhub more often than prescribed.

For more information on pricing see. As an fda approved generic of advair diskus you can expect wixela inhub to be just as effective and safe. Advair diskus was first approved by the fda in august 2000.

Advair diskus and wixela inhub contained qualitatively and quantitatively equivalent formulations of both active pharmaceutical ingredients a fixed dose combination of micronized crystalline fp and salmeterol as xinafoate and inactive excipients lactose monohydrate. Wixela inhub is a generic dry powder inhaler that is available in the same 3 dosage strengths as advair diskus. Patients were randomly assigned to wixela inhub n 512 advair diskus n 512 or placebo n 103.